Lifeboat Foundation

Synthetics startup Ras Labs is working with the International Space Station to test “smart materials” that contract like living tissue. These “electroactive” materials can expand, contract and conform to our limbs just like human muscles when a current moves through them – and they could be used to make robots move and feel more human to the touch.

Ras Labs co-founder Lenore Rasmussen accidentally stumbled upon the synthetic muscle material years ago while mixing chemicals in the lab at Virginia Tech. The experiment turned out to be with the wrong amount of ingredients, but it produced a blob of wobbly jelly that Rasmussen noticed contracted and expanded like muscles when she applied an electrical current.

It would be years later when Rasmussen’s cousin nearly lost his foot in a farming accident that she would start to employ that discovery to robotic limbs and space travel. The co-founder thought her cousin might lose his foot and started researching prosthetics.

Read more

Italian doctor Sergio Canavero, along with his Chinese colleague Ren Xiaoping, is set to conduct the world’s first head transplant on a 30-year-old Russian patient suffering from a rare disease. The operation is planned for December 2017.

The project was first announced in 2013, and the man who volunteered for the procedure is Russian Valery Spiridonov, who suffers from the extremely rare, progressive Werdnig-Hoffmann disease.

“Canavero initially joked it would be a Christmas present, but now this is becoming a reality.

Continue reading “$11mn, 36-hour historic head transplant to be carried out in China in 2017” »

Italian neurosurgeon Sergio Canavero grabbed the world’s attention this past winter when he announced his plans to perform the first human head transplant. Many doubted that such an outrageous procedure would ever see the light of day. Now, Canavero has a date on the books.

Thirty-year-old Russian computer scientist Valery Spiridonov is set to become the world’s first head transplant patient in December 2017. Spiridonov suffers from a rare genetic muscle-wasting condition known as Werdnig-Hoffmann disease. There’s currently no known treatment.

As you might not want to imagine, the procedure will be filled with challenges and uncertainties. There’s the hair-raising possibility that the head will reject the body or vice versa. The spinal cord might not fuse properly. Even if everything goes well, there’s no telling whether Spiridonov’s mental capacities or personality will remain the same. He’s embarking on totally uncharted medical territory.

Read more

Is there anything 3D printers can’t do? A 54-year-old Spanish man, who had a cancerous tumor in his chest wall, was recently fitted with a 3D printed sternum and rib cage. While the first-of-its-kind implant seems like a Marvel Comics experiment with Adamantium, in reality, it was an ingenious, life saving medical solution that used lightweight yet sturdy, Titanium. The metal printing technique gave the surgeons at the Salamanca University Hospital in Spain the flexibility they needed to customize the complex and unique anatomy of their patient’s chest wall.

They brought in Anatomics, a Melbourne-based company that manufactures surgical products, to help create and print the implant. Based on the patient’s high-resolution CT scan data, the Australian team first created a 3D reconstruction of the patient’s chest wall and tumor so that the surgeons could plan with precision. Next, they used the 3D digital CAD file detailing the patient’s anatomy to build the customized implant, layer by layer, on Arcam’s $1.3 million electron beam metal printer.

Read more

Sure, it can beat Ken Jennings at Jeopardy, tell you about your city, and dream up recipes for delectable delicacies, but now, IBM’s Watson is doing something even more important than all previous capabilities combined — it’s finally getting closer to becoming your doctor. Last April, the century-old company launched IBM Watson Health, and now, it’s opened up a new office in Cambridge, Massachusetts, home to some of the best universities in the U.S., and some of the most impressive biotech and pharmaceutical companies as well. In the last few months, Watson has already expanded its scope to take on some of our most pressing health issues and diseases, including cancer and diabetes, and with this new establishment, it seems that the supercomputer will only be taking on greater responsibilities in the industry.

More exciting still is the announcement that Deborah DiSanzo, the former CEO of Philips Healthcare, will be leading the unit as its general manager. Under her leadership, IBM hopes that Watson Health will be able to grow and further expand its massive cloud computing capabilities, which the company believes holds significant potential for modern health care. While current “health record systems can do great job storing data,” Mike Rhodin, senior vice president of the IBM Watson Group, told Fortune, “Watson can summarize that data and incorporate nurse and doctor’s notes to give a more complete picture.”

Related: IBM is bringing sports into the digital age, starting with the U.S. Open.

Read more

Meeting the basic needs of humanity is increasingly brought into question as we begin to resemble a cancer to the living organism we inhabit. As mass extinction continues to become an omnipotent reality, it’s apparent that more humans equals more problems. To fix this, we have to approach them in the same way farmers do: with resiliency. Farmers try to nurture their crops and hope for the right season. Although, even the predictability of spring, summer and fall’s outcome can be misleading. Nature has a way of leading things in the exact opposite direction than they seem to be headed. And it is those who’ve treaded, but still embark that truly encounter the rewards. For if farmers were to give up after an adverse season, there’d be no food next year. There’d be no continuity of supply for society. There’d be no method of feeding the hungry. No solution to ease the growing population and its rising demands.

So, with exponential gain in human births this century, how do we combat such problems? One possible solution is to build “green skyscrapers” for the sole purpose of farming, where we are able to control the environment and have multiple levels of plant growth. This could be done by utilizing an array of mirrors to redirect sunlight to every floor, while supplementing with multi-spectral, energy-efficient LED’s. With advanced humidity control and water-recycling techniques, we’d contribute towards the global conservation of water and open up valuable land to reforestation — all through subjugating the unpredictability of nature. This ensures the utmost quality and care goes into producing local, high-quality food, with the added benefit of honing the technology needed for interplanetary colonization.

Read more

The biology of aging is traditionally studied in fast-living organisms such as mice, worms and fruit flies. Short-lived species certainly have a role to play in this field, but they are only the tip of the iceberg.

Within the natural ecosystem, organisms display a range of aging processes, most often accelerated aging, or gradual aging (in the case of humans), but also, a range of species with slow or even negligible aging, which is known as negligible senescence. Unlike humans, such species have a constant mortality rate for the duration of their lifespan, as well as a constant or even increasing fertility rate. The number of negligibly senescent species which we are currently aware of is likely to grow as more and more are studied and discovered, both in the wild and in the lab.

By studying the processes which give these creatures longer lifespans, there is the possibility that they could be recreated in humans in order to extend our own. How negligible senescence is achieved by each individual species varies, but here are five of the most common traits.

Read more

ALZHEIMER’S could be passed between humans during routine operations including dental work, shocking new research suggests.

Read more

Scientists in the United States said Tuesday they had created a tiny implant which, in mice for now, captures cancer cells spreading through the body.

Cells moving from the original cancer site to infect other organs in a stealthy process called metastasis are usually detected too late to save a patient’s life.

Read more